ARTICLE | Company News
QIMR Berghofer Medical Research Institute, Bristol-Myers deal
October 5, 2015 7:00 AM UTC
Bristol-Myers and QIMR partnered to discover therapeutic antibodies against an undisclosed immuno-oncology target. BMS is responsible for clinical development and commercialization of the antibodies. ...